ArticleCancer cell international2019

The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients.

Serena Salehzadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.